Rensen P C, van Berkel T J
Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, University of Leiden, Sylvius Laboratories, 2300 RA Leiden, The Netherlands.
J Biol Chem. 1996 Jun 21;271(25):14791-9. doi: 10.1074/jbc.271.25.14791.
Apolipoprotein E (apoE) is an important determinant for the liver uptake of triglyceride-rich lipoproteins and emulsions by the remnant receptor. In the current study, we assessed an additional role of apoE as modulator of the metabolism of triglyceride-rich lipoproteins in vitro and in vivo. Glycerol tri[3H]oleate [14C]cholesteryl oleate double-labeled triglyceride-rich emulsions were injected into fasted rats. The serum half-life of glycerol tri[3H]oleate was 3-fold faster (5.4 min) than that of [14C]cholesteryl oleate (16.7 min), confirming lipoprotein lipase (LPL)-mediated processing. To establish a specific effect of apoE on emulsion lipolysis rather than liver uptake, rats were functionally hepatectomized, and hypo(apo)lipoproteinemia was induced by 17alpha-ethinyl estradiol treatment. An apoE concentration-dependent inhibition of emulsion-triglyceride hydrolysis was observed, reaching a 14.8-fold increased half-life of glycerol tri[3H]oleate as compared with that in the absence of exogenous apoE. The mechanism and specificity of the effect of apoE on emulsion lipolysis by purified LPL was assessed in vitro. Addition of apoE to glycerol tri[3H]oleate-labeled emulsions led to a concentration-dependent inhibition of [3H]oleate release (9.5% residual LPL activity at 60 microg/ml apoE), while apoA-I was ineffective. The inhibitory effect of apoE was not abolished by reductive methylation of lysine residues, whereas selective modification of arginine residues by 1,2-cyclohexadione completely cancelled the inhibitory effect of apoE. It is concluded that apoE can specifically inhibit the LPL-mediated hydrolysis of emulsion triglycerides both in vitro and in vivo, and that arginine residues in apoE are essential for this effect. We suggest that in addition to its role in receptor recognition, apoE also modulates the LPL-mediated processing of triglyceride-rich lipoproteins.
载脂蛋白E(apoE)是肝脏通过残粒受体摄取富含甘油三酯的脂蛋白和乳剂的重要决定因素。在本研究中,我们评估了apoE在体外和体内作为富含甘油三酯脂蛋白代谢调节剂的额外作用。将甘油三[³H]油酸酯-[¹⁴C]胆固醇油酸酯双标记的富含甘油三酯的乳剂注射到禁食大鼠体内。甘油三[³H]油酸酯的血清半衰期比[¹⁴C]胆固醇油酸酯的血清半衰期快3倍(5.4分钟对16.7分钟),证实了脂蛋白脂肪酶(LPL)介导的代谢过程。为了确定apoE对乳剂脂解而非肝脏摄取的特定作用,对大鼠进行功能性肝切除,并通过17α-乙炔雌二醇处理诱导低脂蛋白血症。观察到apoE对乳剂甘油三酯水解有浓度依赖性抑制作用,与无外源性apoE时相比,甘油三[³H]油酸酯的半衰期增加了14.8倍。在体外评估了apoE对纯化的LPL介导的乳剂脂解作用的机制和特异性。向甘油三[³H]油酸酯标记的乳剂中添加apoE导致对[³H]油酸酯释放的浓度依赖性抑制(在60μg/ml apoE时残留LPL活性为9.5%),而apoA-I无效。赖氨酸残基的还原甲基化并未消除apoE的抑制作用,而1,2-环己二酮对精氨酸残基的选择性修饰完全消除了apoE的抑制作用。结论是,apoE在体外和体内均可特异性抑制LPL介导的乳剂甘油三酯水解,且apoE中的精氨酸残基对此作用至关重要。我们认为,除了其在受体识别中的作用外,apoE还调节LPL介导的富含甘油三酯脂蛋白的代谢过程。